New Data Presented at Diabetes Technology Society Meeting Support Safe Intravenous Insulin Dosing During Labor and Delivery with EndoTool IV

PALO ALTO, Calif.–(BUSINESS WIRE)–Glooko, Inc., a global digital health company focused on helping clinicians address the growing challenges of glycemic safety and diabetes management across the care continuum, today announced new real-world data presented at the Diabetes Technology Society (DTS) meeting demonstrating the use of EndoTool IV for intravenous insulin dosing during labor and delivery (L&D) in pregnant individuals.The poster, “Use of a Computerized Intravenous Insulin Dosing Ap

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.